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Abstract 
New 1-substituted 3,5-diaryl-2-pyrazolines 13-27 have been synthesized by the reaction of 
hydroxychalcones 1-12 and hydrazines in hot acetic acid solution. Structures of all new 
compounds have been elucidated by microanalyses, 1H- and 13C-NMR spectroscopy. 
 






Pyrazolines are prominent nitrogen-containing heterocyclic compounds and, therefore, various 
procedures have been worked out for their synthesis.1-4 Numerous pyrazoline type compounds 
have been found to possess useful bioactivity, e.g. antimicrobial,5 central nervous system6 and 
immunosuppressive.7 Among the various pyrazoline isomers, 2-pyrazolines appear to be the 
most frequently investigated compounds. As a consequence, a large number of 2-pyrazolines 
have been described in the chemical literature, using different synthetic methods for their 
preparation. An especially popular procedure is based on the reaction of α,β-unsaturated 
aldehydes and ketones with hydrazines.8-37 However, series of specially substituted 
representatives have been prepared rarely. For this reason, the aim of our present study was to 
synthesize systematically hydroxylated 3,5-diaryl-2-pyrazolines for the study of their structure-
activity relationships. 
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Results and Discussion 
 
Formation of 2-pyrazolines by the reaction of α,β-unsaturated ketones and hydrazines may take 
place under various reaction conditions using ethanol,18 acetic acid8-10,16,21,25-27 or pyridine28,29 as 
solvent. After some preliminary experiments, acetic acid was found to be a convenient solvent in 
our present case. Hydroxychalcones 1-12 were allowed to react with hydrazine hydrate or 
phenylhydrazine in hot acetic acid (cf. Experimental Section) to afford 1-substituted 3,5-diaryl-2-
pyrazolines 13-27 in high yields (Scheme 1). N-Acetylation of all 2-pyrazolines obtained by the 
reaction of the appropriate chalcones with hydrazine has taken place under these reaction 
conditions in each case. Formation of the N-acetyl derivatives is beneficial since the 1-
substituted 2-pyrazolines are stable compounds and can be used for biological and 
pharmaceutical trials without the risk of undesirable decomposition. 
 
O









X = H, Ph 12
3 4 5
1-12 13-27
 1, 13: R1 = 2-OH, R2 = 4-iPr, R3 = Ac
2, 14:  R1 = 2-OH, R2 = 4-Cl, R3 = Ac
3, 15: R1 = 2-OH, R2 = 2,4-Cl2, R3 = Ac
4, 16: R1 = 2-OH, R2 = 2,3-(MeO)2, R3 = Ac
5, 17: R1 = 2-OH, R2 = 3,4,5-(MeO)3, R3 = Ac
4, 18: R1 = 2-OH, R2 = 2,3-(MeO)2, R3 = Ph
6, 19: R1 = 2-OH, R2 = 2-Cl, R3 = Ph
7, 20: R1 = 2-OH, R2 = 3-Cl, R3 = Ph
8, 21: R1 = 3-OH, R2 = 4-MeO, R3 = Ac
9, 22: R1 = 3-OH, R2 = 2,6-Cl2, R3 = Ac
9, 23: R1 = 3-OH, R2 = 2,6-Cl2, R3 = Ph
10, 24: R1 = 4-OH, R2 = 2,4-Cl2, R3 = Ac
11, 25: R1 = 4-OH, R2 = 2,6-Cl2, R3 = Ac
12, 26: R1 = 4-OH, R2 = 3,4-Cl2, R3 = Ac





Structures of all new compounds 13-27 have been elucidated by elemental analyses, 1H- and 
13C-NMR measurements. In the 1H-NMR spectra of 2-pyrazolines 13-27, the three hydrogen 
atoms attached to the C-4 and C-5 carbon atoms of the heterocyclic ring gave an ABX spin 
system. Measured chemical shift and coupling constant values (cf. Experimental Section) 
unequivocally prove the 2-pyrazoline structure. In the 1H-NMR spectra of 1-acetyl-2-pyrazolines 
13-17, 21, 22 and 24-36 a singlet signal at around 2.4 ppm refers to the presence of an N-acetyl 
group. In the 13C-NMR spectra of all new 1-substituted 3,5-diaryl-2-pyrazolines 13-27, the 
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chemical shift values of carbon atoms C-3 (154-156 ppm), C-4 (42-44 ppm) and C-5 (56-
58 ppm) corroborate the 2-pyrazoline structure determined by 1H-NMR spectroscopic 
measurements. 13C-NMR chemical shifts of the N-acetyl group also have been assigned in the 
case of compounds 13-17, 21, 22 and 24-26. 
In conclusion, we have synthesized systematically hydroxylated 3,5-diaryl-2-pyrazolines by 
the reaction of hydrazines and chalcones bearing an ortho-, meta- or para-hydroxy group in their 
ring A. These new substances allow the investigation of the possible linkage of the 2-pyrazolines 
to various sites in living organisms in the course of the investigation of their bioactivities. The 
new 1-substituted 3,5-diaryl-2-pyrazolines described in this paper are very stable compounds, a 





General Procedures. Melting points were determined with a Koffler hot-stage apparatus and are 
uncorrected. 1H- and 13C-NMR spectra were recorded on a Varian Gemini 200 spectrometer at 
200/50 MHz in CDCl3 (internal standard TMS, δ = 0.0 ppm) at room temperature. Elemental 
analyses were measured in-house with a Carlo Erba 1106 EA instrument. TLC was performed on 
Kieselgel 60 F254 (Merck) layer using hexane:acetone (7:3 v/v) or toluene:ethyl acetate (4:1 v/v) 
as eluents. Starting materials 1-12 were synthesized according to known procedures.38-41 
 
General procedure for the synthesis of compounds 13-27 
A mixture of hydroxychalcone (1-12, 10.0 mmoles), hydrazine hydrate (50.0 mmoles) or 
phenylhydrazine (50.0 mmoles) and acetic acid (40 ml) was refluxed for 3 hours then poured into 
water. The precipitate was separated by filtration, washed free of acid and crystallized from 
methanol to afford 2-pyrazolines 13-27 (Scheme 1). 
 
1-Acetyl-3-(2-hydroxyphenyl)-5-(4-isopropylphenyl)-2-pyrazoline (13). This compound was 
obtained as colourless needles in 65% yield, m.p. 163-164 oC; 1H-NMR (δ): 1.22 (6H, d, J = 6.9 
Hz, CH(CH3)2), 2.38 (3H, s, CH3), 2.89 (1H, m, CH(CH3)2), 3.31 (1H, dd, J = 4.6, 17.8 Hz, 4-
Htrans), 3.85 (1H, dd, J = 11.8, 17.8 Hz, 4-Hcis), 5.57 (1H, dd, J = 4.6, 11.8 Hz, 5-H), 6.90-7.41 
(m, 8 arom. H), 10.30 (1H, s, OH); 13C-NMR (δ): 21.9, 23.7, 33.6, 42.6, 58.1, 115.3, 117.2, 
119.8, 125.7, 127.2, 128.6, 132.4, 138.7, 148.8, 156.6, 157.9, 167.9. Anal. Calcd. for 
C20H22N2O2: C, 74.51; H, 6.88; N, 8.68. Found: C, 74.59; H, 6.84; N, 8.76. 
1-Acetyl-5-(4-chlorophenyl)-3-(2-hydroxyphenyl)-2-pyrazoline (14). This material was 
isolated as colourless needles in 76% yield, m.p. 146-147 oC; 1H-NMR (δ): 2.38 (3H, s, CH3), 
3.28 (1H, dd, J = 4.8, 17.9 Hz, 4-Htrans), 3.84 (1H, dd, J = 12.0, 17.9 Hz, 4-Hcis), 5.54 (1H, dd, J = 
4.8, 12.0 Hz, 5-H), 6.92-7.41 (m, 8 arom. H), 10.21 (1H, s, OH); 13C-NMR (δ): 21.8, 42.4, 57.7, 
115.0, 117.2, 119.9, 127.2, 128.5, 129.3, 132.5, 133.9, 139.8, 156.3, 157.9, 167.9. Anal. Calcd. 
for C17H15ClN2O2: C, 64.87; H, 4.80; N, 8.89. Found: C, 64.98; H, 4.83; N, 8.96. 
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1-Acetyl-5-(2,4-dichlorophenyl)-3-(2-hydroxyphenyl)-2-pyrazoline (15). This substance was 
prepared as pale yellow needles in 71% yield, m.p. 183-184 oC; 1NMR (δ): 2.43 (3H, s, CH3), 
3.16 (1H, dd, J = 5.3, 18.0 Hz, 4-Htrans), 3.92 (1H, dd, J = 12.0, 18.0 Hz, 4-Hcis), 5.80 (1H, dd, J = 
5.3, 12.0 Hz, 5-H), 6.86-7.42 (m, 7 arom. H), 10.17 (1H, s, OH); 13C-NMR (δ): 21.8, 41.6, 55.9, 
114.9, 117.3, 119.9, 127.2, 127.8, 128.6, 130.1, 132.7, 134.4, 136.7, 156.8, 157.9, 168.1. Anal. 
Calcd. for C17H14Cl2N2O2: C, 58.47; H, 4.04; N, 8.02. Found: C, 58.57; H, 4.07; N, 8.10. 
1-Acetyl-5-(2,3-dimethoxyphenyl)-3-(2-hydroxyphenyl)-2-pyrazoline (16). This comp-ound 
was prepared as colourless plates in 69% yield, m. p. 166-167 oC; 1H-NMR (δ): 2.39 (3H, s, 
CH3), 3.24 (1H, dd, J = 5.1, 17.8 Hz, 4-Htrans), 3.80 (1H, dd, J = 12.0, 17.8 Hz, 4-Hcis), 3.84 (3H, 
s, CH3O), 3.89 (3H, s, CH3O), 5.72 (1H, dd, J = 5.1, 12.0 Hz, 5-H), 6.72-7.37 (m, 7 arom. H), 
10.34 (1H, s, OH); 13C-NMR (δ): 21.9, 42.0, 54.5, 55.6, 60.2, 112.1, 115.3, 116.9, 118.6, 119.7, 
124.4, 128.6, 132.2, 134.9, 146.1, 153.1, 157.2, 157.9, 167.8. Anal. Calcd. for C19H20N2O4: C, 
67.04; H, 5.92; N, 8.23. Found: C, 67.15; H, 5.86; N, 8.31. 
1-Acetyl-3-(2-hydroxyphenyl)-5-(3,4,5-trimethoxyphenyl)-2-pyrazoline (17). This subs-tance 
was isolated as colourless needles in 68% yield, m.p. 154-155 oC; 1H-NMR (δ): 2.42 (3H, s, 
CH3), 3.31 (1H, dd, J = 5.0, 18.0 Hz, 4-Htrans), 3.80 (3H, s, CH3O), 3.84 (6H, s, 2CH3O), 3.90 
(1H, dd, J = 11.8, 18.0 Hz, 4-Hcis), 5.49 (1H, dd, J = 5.0, 11.8 Hz, 5-H), 6.89-7.41 (m, 6 arom. 
H), 10.28 (1H, s, OH); 13C-NMR (δ): 21.7, 41.2, 55.3, 57.3, 111.7, 116.5, 119.3, 127.1, 127.7, 
129.9, 132.5, 134.0, 137.4, 154.2, 160.0, 169.1. Anal. Calcd. for C20H22N2O5: C, 64.85; H, 5.99; 
N, 7.56. Found: C, 64.92; H, 5.93; N, 7.64. 
5-(2,3-Dimethoxyphenyl)-3-(2-hydroxyphenyl)-1-phenyl-2-pyrazoline (18). This material was 
prepared as yellow needles in 70% yield, mp. 127-128 oC; 1H-NMR (δ): 3.23 (1H, dd, J = 6.9, 
17.6 Hz, 4-Htrans), 3.90 (3H, s, CH3O), 3.98 (3H, s, CH3O), 4.02 (1H, dd, J = 11.3, 17.6 Hz, 4-
Hcis), 5.02 (1H, dd, J = 6.9, 11.3 Hz, 5-H), 6.82-7.83 (m, 12 arom. H), 10.89 (1H, s, OH); 13C-
NMR (δ): 42.8, 55.7, 58.1, 60.6, 111.9, 116.6, 118.7, 119.4, 119.8, 124.8, 127.3, 130.4, 135.5, 
144.2, 146.0, 150.3, 153.1, 157.4. Anal. Calcd. for C23H22N2O3: C, 73.78; H, 5.92; N, 7.48. 
Found: C, 73.89; H, 5.86; N, 7.57. 
5-(2-Chlorophenyl)-3-(2-hydroxyphenyl)-1-phenyl-2-pyrazoline (19). This compound was 
prepared as pale yellow plates in 66% yield, m.p. 121-122 oC; 1H-NMR (δ): 3.14 (1H, dd, J = 
7.0, 17.6 Hz, 4-Htrans), 4.04 (1H, J = 12.1, 17.6 Hz, 4-Hcis), 5.58 (1H, dd, J = 7.0, 12.1, 5-H), 
6.80-7.49 (m, 13 arom. H), 10.70 (1H, s, OH); 13C-NMR (δ): 42.2, 60.0, 113.2, 116.3, 116.7, 
119.5, 120.1, 127.4, 127.9, 129.2, 129.4, 130.2, 130.7, 131.9, 138.8, 143.8, 150.2, 157.4. Anal. 
Calcd. for C21H17ClN2O: C,n 72.31; H, 4.91; N, 8.03. Found: C, 72.40; H, 4.87; N, 8.09. 
5-(3-Chlorophenyl)-3-(2-hydroxyphenyl)-1-phenyl-2-pyrazoline (20). This substance was 
obtained as yellow plates in 72% yield, m.p. 122-123 oC; 1H-NMR (δ): 3.22 (1H, dd, J = 7.6, 
17.3 Hz, 4-Htrans), 3.96 (1H, dd, J = 12.1, 17.3 Hz, 4-Hcis), 5.20 (1H, dd, J = 7.6, 12.1 Hz, 5-H), 
6.82-7.40 (m, 13 arom. H), 10.70 (1H, s, OH); 13C-NMR (δ): 43.8, 62.8, 113.5, 116.2, 116.8, 
119.5, 120.4, 124.2, 126.2, 127.3, 128.3, 129.3, 130.8, 135.3, 144.1, 149.8, 157.5. Anal. Calcd. 
for C21H17ClN2O: C, 72.31, H, 4.91; N, 8.03. Found: 72.22; H, 4.97; N, 7.94. 
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1-Acetyl-3-(3-hydroxyphenyl)-5-(4-methoxyphenyl)-2-pyrazoline (21). This material was 
prepared as colourless plates in 62% yield, m.p. 211-212 oC; 1H-NMR (δ): 2.26 (3H, s, CH3), 
3.04 (1H, dd, J = 4.5, 18.0 Hz, 4-Htrans), 3.70 (3H, s, CH3O), 3.80 (1H, dd, J = 11.7, 18.0 Hz, 4-
Hcis), 5.47 (1H, dd, J = 4.5, 11.7 Hz, 5-H), 6.84-7.30 (m, 8 arom. H), 10.24 (1H, s, OH); 13C-
NMR (δ): 21.6, 42.0, 55.0, 58.8, 112.9, 117.6, 117.8, 126.9, 129.9, 132.6, 134.6, 154.3, 157.8, 
158.7, 167.5. Anal. Calcd. for C18H18N2O3: C, 69.66; H, 5.85; N, 9.02. Found: C, 69.78; H, 5.90; 
N, 9.09. 
1-Acetyl-5-(2,6-dichlorophenyl)-3-(3-hydroxyphenyl)-2-pyrazoline (22). This compound was 
prepared as yellow needles in 70% yield, m.p. 252-253 oC; 1H-NMR (δ): 2.38 (3H, s, CH3), 3.27 
(1H, dd, J = 8.5, 17.8 Hz, 4-Htrans), 3.67 (1H, dd, J = 12.8, 17.8 Hz, 4-Hcis), 6.21 (1H, dd, J = 8.5, 
12.8 Hz, 5-H), 6.89-7.39 (m, 7 arom. H), 10.42 (1H, s, OH); 13C-NMR (δ): 21.2, 40.7, 56.2, 
112.9, 117.6, 128.7, 129.7, 130.0, 130.2, 132.4, 133.0, 135.1, 135.5, 154.3, 157.8, 167.7. Anal. 
Calcd. for C17H14Cl2N2O2: C, 58.47; H, 4.04; N, 8.02. Found: C, 58.41; H, 4.01; N, 8.07. 
5-(2,6-Dichlorophenyl)-3-(3-hydroxyphenyl)-1-phenyl-2-pyrazoline (23). This substance was 
obtained as yellow plates in 73% yield, m.p. 206-207 oC; 1H-NMR (δ): 3.31 (1H, dd, J = 7.3, 
17.7 Hz, 4-Htrans), 3.79 (1H, dd, J = 11.4, 17.7 Hz, 4-Hcis), 6.08 (1H, dd, J = 7.3, 11.4 Hz, 5-H), 
6.76-7.45 (m, 12 arom. H), 10.31 (1H, s, OH); 13C-NMR (δ): 39.7, 60.0, 112.3, 113.2, 115.8, 
118.6, 119.5, 128.6, 129.1, 129.4, 129.9, 130.9, 134.4, 135.2, 135.3, 135.8, 144.6, 146.2, 155.9. 
Anal. Calcd. for C21H16Cl2N2O: C, 65.81; H, 4.21; N, 7.30. Found: C, 65.93; H, 4.27; N, 7.22. 
1-Acetyl-5-(2,4-dichlorophenyl)-3-(4-hydroxyphenyl)-2-pyrazoline (24). This material was 
obtained as yellow plates in 64% yield, m.p. 240-241 oC; 1H-NMR (δ): 2.31 (3H, s, CH3), 3.01 
(1H, dd, J = 4.8, 18.0 Hz, 4-Htrans), 3.88 (1H, dd, J = 11.8, 18.0 Hz, 4-Hcis), 5.69 (1H, dd, J = 4.8, 
11.8 Hz, 5-H), 6.83-7.66 (m, 7 arom. H), 10.01 (1H, s, OH); 13C-NMR (δ): 21.4, 40.8, 56.6, 
115.7, 121.9, 127.9, 128.0, 128.6, 129.3, 131.9, 132.7, 138.5, 154.6, 159.9, 167.5. Anal. Calcd. 
for C17H14Cl2N2O2: C, 58.47; H, 4.04; N, 8.02. Found: C, 58.53; H, 4.07; N, 8.09. 
1-Acetyl-5-(2,6-dichlorophenyl)-3-(4-hydroxyphenyl)-2-pyrazoline (25). This compound was 
prepared as pale yellow needles in 70% yield, m.p. 261-262 oC; 1H-NMR (δ): 2.20 (3H, s, CH3), 
3.15 (1H, dd, J = 7.9, 18.0 Hz, 4-Htrans), 3.80 (1H, dd, J = 12.9, 18.0 Hz, 4-Hcis), 6.06 (1H, dd, J = 
7.9, 12.9 Hz, 5-H), 6.84-7.65 (m, 7 arom. H), 9.98 (1H, s, OH); 13C-NMR (δ): 21.2, 40.7, 56.0, 
115.7, 122.1, 128.5, 128.8, 129.7, 130.2, 133.0, 135.1, 135.7, 154.3, 159.8, 167.4. Anal. Calcd. 
for C17H14Cl2N2O2: C, 58.47; H, 4.04; N, 8.02. Found: C, 58.39; H, 3.99; N, 8.08. 
1-Acetyl-5-(3,4-dichlorophenyl)-3-(4-hydroxyphenyl)-2-pyrazoline (26). This substance was 
isolated as yellow plates in 67% yield, m.p. 254-255 oC; 1H-NMR (δ): 2.28 (3H, s, CH3), 3.12 
(1H, dd, J = 4.9, 18.1 Hz, 4-Htrans), 3.79 (1H, dd, J = 11.7, 18.1 Hz, 4-Hcis), 5.51 (1H, dd, J = 4.9, 
11.7 Hz, 5-H), 6.83-7.64 (m, 7 arom. H), 10.01 (1H, s, OH); 13C-NMR (δ): 21.5, 41.8, 58.2, 
115.7, 122.0, 126.1, 128.1, 128.7, 129.9, 131.1, 143.7, 154.6, 159.9, 167.6. Anal. Calcd. for 
C17H14Cl2N2O2: C, 58.47; H, 4.04, N, 8.02. Found: C, 58.56; H, 4.07; N, 8.09. 
5-(2,4-Dichlorophenyl)-3-(4-hydroxyphenyl)-1-phenyl-2-pyrazoline (27). This substance was 
prepared as yellow plates in 83% yield, m.p. 125-126 oC; 1H-NMR (δ): 3.01 (1H, dd, J = 6.9, 
17.2 Hz, 4-Htrans), 3.94 (1H, dd, J = 11.8, 17.2 Hz, 4-Hcis), 5.51 (1H, dd, J = 6.9, 11.8 Hz, 5-H), 
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6.75-7.62 (m, 12 arom. H), 10.30 (1H, s, OH); 13C-NMR (δ): 41.9, 60.8, 113.2, 115.7, 119.4, 
125.5, 127.7, 128.1, 128.6, 129.2, 129.8, 132.6, 134.0, 138.2, 144.8, 147.4, 156.6. Anal. Calcd. 
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